Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ISCO | US
-0.01
-4.83%
Healthcare
Biotechnology
30/06/2024
20/03/2026
0.14
0.15
0.17
0.14
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
120.0%1 month
89.3%3 months
154.9%6 months
151.7%-
-
-
-
-
166.00
0.41
-
-356.00K
1.09M
1.09M
-
6.39
-74.20
26.60
-185.37
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.04
Range1M
0.04
Range3M
0.06
Rel. volume
2.51
Price X volume
2.04K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Orgenesis Inc | ORGS | Biotechnology | 0.25 | 1.19M | -16.67% | n/a | -84.02% |
| XORTX Therapeutics Inc. Common Stock | XRTX | Biotechnology | 0.395 | 1.19M | -3.66% | n/a | 3.09% |
| RedHill Biopharma Ltd | RDHL | Biotechnology | 0.879 | 1.13M | -0.99% | n/a | 65.80% |
| Phio Pharmaceuticals Corp | PHIO | Biotechnology | 1.22 | 1.05M | 3.39% | n/a | 0.00% |
| Galmed Pharmaceuticals Ltd | GLMD | Biotechnology | 0.6 | 904.19K | 2.83% | n/a | 0.00% |
| Evofem Biosciences Inc | EVFM | Biotechnology | 0.0085 | 852.80K | 0.00 | 0.00% | |
| Pasithea Therapeutics Corp. Common Stock | KTTA | Biotechnology | 0.797 | 832.79K | 1.91% | n/a | 0.00% |
| Virax Biolabs Group Limited Ordinary Shares | VRAX | Biotechnology | 0.1732 | 752.03K | -4.63% | n/a | 4.18% |
| Innovation Pharmaceuticals Inc | IPIX | Biotechnology | 0.0008 | 414.68K | 0.00% | n/a | 20.48% |
| Biodexa Pharmaceticals | BDRX | Biotechnology | 0.7006 | 406.94K | 2.25% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | -2.34% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 166.00 | - | Expensive |
| Ent. to Revenue | 0.41 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 154.94 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 1.09M | - | Emerging |